Half of the Israeli companies which qualified for grants in the SME Instrument Program are startups specializing in the environment and in energy. Other fields in which Israeli companies received grants: Information Technology, Communications, Nanotechnologies, Materials and New Production Technologies' (NMP), Biotechnology and Transportation.
One of the companies is NMATECH – an Israeli company that developed an innovative polymer resistant to wear and erosion, which is biologically adapted to the human body, for use in moving joints like thighs and knees. The company has already started clinical trials abroad and has conducted 55 hip joint replacements using this technology.
Another company that won a grant: TerraGenic – this groundbreaking Israeli company is developing a substitute fuel for batteries. The company is developing a novel fuel, rich in hydrogen intended for use in batteries. These batteries will be able to hold five times as much power as current ones and will be able to be fully recharged in a matter of seconds. The battery is intended to power smart phones in the future and will last five days between recharging.
The SME Instrument program of the EU's Horizon 2020 is focused on small- and medium-sized R&D companies which employ fewer than 250 workers, are not owned by corporations, with revenues under €50 million
The program is open to submissions for Israeli companies four times a year and has two separate "phases" of support and financing. In the program's shorter phase 1, a company can receive a fixed €50,000 grant and in phase 2, grants can range from €500,000 to €2,500,000. In addition, companies that receive grants from either phase can receive free business consultation from advisers chosen from a list of more than 1000 experts throughout Europe from any number of fields. Both phases are in principle meant to support companies with products at least at the lab demo stage, which are planning to move from development to production and the "go to market" stage.